Question 1

What do FDA Category 1, Category 2, and Category 3 mean for peptides?

Accepted Answer

Category 1 means FDA is still evaluating the nominated substance, so the ingredient has a better interim posture than a flagged peptide but not the same certainty as an approved drug pathway. Category 2 means FDA identified meaningful safety concerns. Category 3 means the nomination did not have enough support to stay under active evaluation, which also makes routine compounding difficult to defend.

Question 2

What if a peptide is not even on the FDA 503A bulks list process?

Accepted Answer

That is usually a worse compounding posture than Category 1. If FDA says a substance is not the subject of an applicable USP or NF monograph, is not a component of an FDA-approved human drug, and does not appear on the 503A bulks list, pharmacies have little basis to treat it as a routine compounded ingredient.

Question 3

What if a popular peptide has no clear FDA category or warning-letter signal yet?

Accepted Answer

We still may track it if search demand is high, but we label it conservatively. In that case, the page should make clear that there is no clean FDA category signal or approved-drug pathway we can point to yet, and that online popularity is not the same as a lawful compounding basis.

Question 4

Can my doctor prescribe BPC-157 right now?

Accepted Answer

A doctor can discuss it, but a prescription does not guarantee a pharmacy can lawfully compound and dispense it. BPC-157 remains treated as restricted for routine compounding use, so availability is limited.

Question 5

What is the RFK reclassification announcement people keep referencing?

Accepted Answer

People in the peptide market are referring to political and agency reform rhetoric around re-evaluating peptide restrictions. Until the FDA formally changes category guidance, those statements are only directional signals, not legal authorization.

Question 6

Are research peptides the same thing as legal prescription peptides?

Accepted Answer

No. Research-use labeling does not make a peptide legal for human prescribing or compounding. A peptide can still be widely sold online while remaining non-compoundable for pharmacies.

Question 7

What is the difference between 503A and 503B pharmacies?

Accepted Answer

503A pharmacies compound patient-specific prescriptions. 503B outsourcing facilities compound at larger scale for office use. A peptide can be difficult or impossible to justify in both settings depending on the FDA category and the available evidence.

Question 8

Is buying peptides online legal?

Accepted Answer

Online availability is not the same as lawful medical distribution. Sellers may market peptides as research compounds or supplements even when they are not legal for routine pharmacy compounding or prescription use.

Question 9

Do state laws matter if the federal status is already restrictive?

Accepted Answer

Yes. State boards can be even more conservative than federal guidance, especially for sterile compounding or wellness clinics. That is why a peptide may be harder to source in California or New York than elsewhere.

The legal questions people keep asking about peptides.